background
rotavirus
singl
import
caus
sever
diarrhea
young
children
worldwid
develop
specif
potent
access
antivir
treatment
restrain
rotaviru
infect
remain
import
control
rotaviru
diseas
method
plant
extract
nutrit
applic
screen
vitro
cell
antivir
activ
rhesu
rotaviru
rrv
one
extract
aspalathu
lineari
burmf
rdahlgren
also
test
effect
loss
transepitheli
resist
ter
cell
caus
simian
rotaviru
infect
result
aqueou
extract
nelumbo
nucifera
gaertn
fruit
urtica
dioica
l
root
aspalathu
lineari
burmf
r
dahlgren
leav
glycyrrhiza
glabra
l
root
olea
europaea
l
leav
found
strong
signific
antivir
activ
inhibitori
concentr
pure
compound
acid
glycyrrhiza
glabra
found
strongest
antivir
activ
follow
luteolin
vitexin
aspalathu
lineari
respect
melissa
officinali
combin
glycyrrhiza
glabra
l
nelumbo
nucifera
gaertn
urtica
dioica
l
nelumbo
nucifera
gaertn
show
synergi
antivir
activ
aspalathu
lineari
burmf
rdahlgren
show
posit
effect
mainten
ter
result
indic
nutrit
intervent
extract
nelumbo
nucifera
gaertn
aspalathu
lineari
burmf
rdahlgren
urtica
dioica
l
glycyrrhiza
glabra
l
olea
europaea
l
might
use
treatment
diarrhea
caus
rotaviru
infect
rotaviru
still
one
lead
caus
sever
dehydr
diarrhea
children
age
five
caus
death
children
younger
year
annual
rotavirus
belong
genu
doublestrand
rna
virus
famili
reovirida
infect
matur
villou
epitheli
cell
small
intestin
often
lead
fever
vomit
diarrhea
children
treatment
rotaviru
gastroenter
intraven
fluid
administr
use
success
treat
direct
consequ
dehydr
diarrhea
gastrogardr
w
prophylact
treatment
risk
children
age
one
month
three
year
prevent
diarrhea
due
rotaviru
infect
efficaci
treatment
establish
clinic
trial
children
age
month
gastrogardr
w
prepar
colostrum
hyperimmunis
cow
contain
immunoglobulin
serotyp
human
rotaviru
demonstr
vivo
rotaviru
infect
mous
model
gastrogardr
w
abl
complet
inhibit
rotavirusinduc
diarrhea
suckl
mice
first
gener
licens
rotaviru
vaccin
withdrawn
market
year
introduct
due
possibl
correl
vaccin
applic
occurr
intussuscept
two
liveattenu
vaccin
licens
recent
far
proven
safe
highli
efficaci
develop
countri
develop
countri
clinic
trial
undertaken
earli
result
found
vaccin
significantli
reduc
sever
diarrhea
episod
due
rotaviru
asia
africa
howev
rotaviru
vaccin
expens
may
afford
develop
world
present
compromis
full
vaccin
coverag
reinforc
need
develop
altern
approach
control
rotaviru
diseas
natur
compound
identifi
ideal
candid
antivir
drug
cheaper
effect
date
mani
natur
compound
known
antirotaviru
effect
clinic
studi
anim
experi
vitro
current
studi
investig
edibl
plant
extract
natur
compound
vitro
antirotaviru
infect
effect
cell
establish
cell
line
rotaviru
infect
studi
rotaviru
receptor
identifi
cell
trypsin
usual
ad
infect
cell
rotaviru
increas
infect
intestin
epitheli
permeabl
studi
often
perform
human
cell
cell
develop
polar
distinct
apic
basolater
surfac
separ
tight
junction
area
celltocel
contact
close
resembl
physiolog
situat
intestin
transepitheli
resist
ter
measur
tight
tight
junction
form
cell
rotavirus
known
infect
epitheli
cell
small
intestin
vitro
rotaviru
infect
cell
caus
disrupt
tight
junction
loss
ter
absenc
cell
death
investig
whether
loss
ter
could
prevent
cell
infect
rotaviru
presenc
hyperimmun
colostrum
gastrogardr
w
plant
extract
pure
compound
model
result
aqueou
plant
extract
antivir
action
rotaviru
present
search
novel
agent
treatment
human
diarrhea
caus
rotaviru
infect
cell
african
green
monkey
kidney
cell
ecacc
salisburi
uk
cell
human
caucasian
colon
adenocarcinoma
ecacc
maintain
eagl
minim
essenti
medium
mem
life
technolog
breda
netherland
supplement
fetal
calf
serum
fc
greiner
bioon
alphen
ad
rijn
netherland
mm
sodium
pyruv
life
technolog
nonessenti
amino
acid
life
technolog
virus
select
studi
simian
rotaviru
strain
atcc
rhesu
rotaviru
rrv
strain
kindli
provid
dr
richard
ward
cincinnati
children
hospit
medic
center
usa
virus
grown
cell
concentr
ultracentrifug
titer
determin
use
titrat
assay
cell
result
cell
cultur
infect
dose
rrv
hyperimmun
colostrum
gastrogardr
w
plant
extract
pure
compound
hyperimmun
colostrum
hic
gastrogardr
w
nutricia
adelaid
australia
test
titrat
assay
cell
concentr
medium
transepitheli
resist
measur
concentr
medium
plant
extract
known
nutrit
applic
select
hous
herbal
extract
collect
purchas
phytomyco
research
pvt
ltd
mysor
district
karnataka
state
india
consist
herbal
extract
setup
high
throughput
screen
plant
extract
test
first
screen
antivir
titrat
assay
cell
concentr
medium
inhibit
infect
determin
inhibit
inhibitori
concentr
valu
calcul
extract
reduc
rotaviru
infect
studi
two
concentr
close
calcul
extract
unabl
inhibit
infect
appoint
arbitrari
complet
list
test
herbal
extract
list
addit
file
synergi
two
plant
extract
investig
titrat
assay
assay
separ
compound
well
combin
hereof
plate
separ
compound
test
calcul
concentr
wherea
combin
mixtur
concentr
extract
acid
sigmaaldrich
st
loui
usa
test
concentr
medium
luteolin
vitexin
indofin
chemic
compani
hillsborough
usa
test
concentr
medium
complet
list
test
compound
list
addit
file
confluent
cell
plate
first
incub
variou
concentr
plant
extract
twofold
titrat
rang
rrv
start
ad
presenc
mg
trypsinml
life
technolog
one
well
cell
incub
highest
concentr
extract
control
infect
cell
rotaviru
induc
syncytium
day
visibl
microscopi
titrat
rrv
use
measur
maximum
infect
sum
infect
well
consid
infect
inhibit
plant
extract
calcul
maximum
infect
maximum
infect
concentr
plant
extract
test
duplic
ter
measur
tight
tight
junction
form
cell
one
electrod
epitheli
voltohm
meter
world
precis
instument
sarasota
usa
place
apic
compart
transwel
system
corn
life
scienc
new
jersey
usa
basolater
compart
electr
resist
measur
across
cell
monolay
passag
defin
current
puls
experi
carri
two
week
post
confluenc
fulli
differenti
cell
one
day
infect
cell
cultur
medium
without
fc
prior
infect
rotaviru
inoculum
activ
min
treatment
mg
trypsinml
invitrogen
cell
apic
infect
inoculum
activ
rotaviru
presenc
extract
incub
co
integr
confluent
polar
monolay
check
measur
ter
voltohmmet
ter
unit
ohm
time
centimet
squar
calcul
measur
electr
resist
time
surfac
area
filter
background
read
control
filter
measur
everi
experi
infect
carri
triplic
measur
done
variou
time
point
post
infect
permeabl
cell
monolay
also
determin
measur
paracellular
passag
hrp
fitcdextran
apic
basolater
compart
cultur
chamber
concentr
fitcdextran
determin
measur
fluoresc
excit
nm
emiss
nm
concentr
hrp
determin
incub
sampl
tmb
min
rt
reaction
stop
h
absorb
measur
nm
cell
cultur
infect
dose
rrv
calcul
accord
reed
muench
statist
method
inhibitori
concentr
valu
determin
calcul
statist
valid
nonlinear
regress
curv
plot
acquir
valu
xvalu
ie
dosag
correspond
maxim
yvalu
divid
calcul
mathemat
regress
curv
formula
hyperimmun
colostrum
gastrogardr
w
hyperimmun
colostrum
hic
use
posit
control
therefor
test
antivir
titrat
assay
cell
sever
concentr
figur
concentr
show
inhibit
infect
compar
maximum
infect
rrv
effect
two
rotaviru
strain
transepitheli
resist
ter
cell
first
determin
rotaviru
strain
rrv
show
decreas
ter
infect
result
also
progress
increas
paracellular
permeabl
hrp
kd
molecul
fitcdextran
kd
molecul
correl
time
post
infect
data
shown
declin
ter
cell
effect
hic
ter
infect
depict
figur
infect
cell
result
declin
ter
infect
presenc
hic
show
complet
mainten
ter
compar
noninfect
cell
presenc
hic
studi
edibl
plant
extract
dissolv
medium
perform
investig
inhibitori
effect
rotaviru
infect
cell
figur
eleven
extract
abl
inhibit
rotaviru
infect
inhibitori
concentr
among
extract
differ
urtica
dioica
l
differ
nelumbo
nucifera
gaertn
differ
aspalathu
lineari
burmf
rdahlgren
differ
glycyrrhiza
glabra
l
extract
one
olea
europea
l
extract
potent
extract
plant
togeth
eleven
moder
inhibitor
rotaviru
infect
depict
figur
aspalathu
lineari
burmf
rdahlgren
also
test
effect
ter
posit
effect
mainten
ter
measur
twentyfour
pure
compound
known
present
strong
moder
inhibitori
plant
extract
test
antivir
titrat
assay
concentr
four
compound
show
inhibitori
effect
acid
glycyrrhiza
glabra
found
strongest
antivir
activ
follow
luteolin
vitexin
aspalathu
lineari
respect
melissa
officinali
also
test
effect
ter
posit
effect
mainten
ter
measur
synerg
phenomenon
combin
action
two
extract
greater
sum
individu
effect
extract
two
combin
plant
extract
show
synergi
depict
figur
glycyrrhiza
glabra
l
inhibit
infect
nelumbo
nucifera
gaertn
ml
wherea
combin
glycyrrhiza
nelumbo
show
inhibit
also
seen
combin
urtica
dioica
l
nelumbo
nucifera
gaertn
urtica
dioica
l
inhibit
infect
nelumbo
nucifera
gaertn
combin
urtica
nelumbo
ml
show
inhibit
infect
recent
grow
interest
interact
pharmacolog
nutrit
scienc
pharmaceut
gener
develop
treat
cure
prevent
diseas
primari
goal
nutrit
maintain
even
improv
health
impli
role
nutrit
prevent
cure
diseas
plant
extract
use
screen
select
known
nutrit
use
nutrit
applic
antivir
activ
five
strongest
rotaviru
inhibitor
discuss
nelumbo
nucifera
sacr
water
lotu
well
known
food
ingredi
europ
asia
root
often
eaten
veget
soup
deepfri
stirfri
brais
dish
nelumbo
nucifera
known
antivir
action
hiv
herp
simplex
viru
hsv
aspalathu
lineari
leav
use
make
redbush
tea
popular
southern
africa
gener
consum
mani
countri
antivir
activ
report
yet
aspalathu
lineari
urtica
dioica
sting
nettl
use
varieti
recip
nettl
soup
common
use
plant
particularli
northern
eastern
europ
nepal
northern
india
popular
veget
cook
indian
spice
known
antivir
action
urtica
dioica
inhibit
hiv
fiv
felin
variant
hiv
glycyrrhiza
glabra
also
known
european
licoric
root
extract
use
flavor
sweet
bake
good
ice
cream
soft
drink
one
member
glycyrrhiza
sp
glycyrrhiza
uralensi
chines
licoric
alreadi
know
literatur
antivir
activ
rotaviru
glycyrrhiza
glabra
known
inhibitori
activ
sever
unrel
dna
rna
virus
olea
europea
fruit
oliv
major
agricultur
import
mediterranean
region
sourc
oliv
oil
olea
europea
exhibit
antivir
activ
viral
haemorrhag
septicaemia
rhabdoviru
vhsv
nutrit
ingredi
demonstr
antirotaviru
activ
vitro
illustr
potenti
use
specif
plant
extract
treatment
prevent
rotaviru
ill
twentyfour
pure
compound
known
present
strong
moder
rotaviru
inhibitori
plant
extract
test
antivir
titrat
assay
compound
show
antivir
activ
acid
constitu
glycyrrhiza
glabra
strongest
inhibitor
glycyrrhiz
acid
one
bioactiv
compound
licoric
root
compos
one
molecul
acid
steroidlik
structur
two
molecul
glucuron
acid
lin
et
al
report
acid
stronger
action
epsteinbarr
viru
parent
compound
glycyrrhiz
acid
two
constitu
aspalathu
lineari
luteolin
vitexin
also
show
antivir
activ
rotaviru
antivir
titrat
assay
luteolin
flavonoid
often
found
leav
vitexin
apigenin
flavon
glucosid
compound
found
mani
differ
plant
speci
aspalathu
weakest
inhibitor
apigenin
also
flavonoid
found
exampl
lemon
balm
melissa
officinali
chamomil
chamomilla
recutita
celeri
apium
graveolen
far
know
first
studi
show
luteolin
vitexin
apigenin
antivir
activ
vitro
although
mechan
action
yet
defin
first
step
potenti
wider
pharmacolog
use
nutrit
ingredi
possibl
activ
compound
present
posit
plant
extract
investig
posit
control
hyperimmun
colostrum
hic
show
inhibitori
action
rotaviru
infect
antivir
titrat
assay
rrv
cell
well
maintain
ter
cell
infect
synerg
studi
extract
combin
concentr
synerg
antivir
activ
found
combin
glycyrrhiza
glabra
l
nelumbo
nucifera
gaertn
urtica
dioica
l
nelumbo
nucifera
gaertn
separ
extract
concentr
show
inhibit
infect
combin
concentr
extract
show
inhibit
respect
indic
extract
combin
differ
antivir
action
illustr
import
research
mechan
action
individu
ingredi
well
vivo
valid
antivir
capac
level
antivir
activ
test
vitro
use
indic
therapeut
benefit
compon
vivo
within
studi
aspect
relat
toxic
tast
stabil
avail
durat
supplement
regul
drug
interact
pharmacokinet
profil
taken
account
therefor
statement
current
made
regard
vivo
applic
nutrit
compound
howev
sinc
herb
current
use
nutrit
ingredi
rotaviru
intestin
pathogen
clear
potenti
intervent
describ
within
sever
studi
natur
extract
test
antivir
capac
although
isol
activ
compound
shown
antivir
activ
valu
rang
mgml
mgml
crude
extract
time
reach
antivir
activ
mgml
therefor
crude
extract
reach
mgml
regard
strong
inhibitor
moreov
specifi
extract
activ
compound
bioavail
activ
vivo
therefor
addit
research
field
need
potenti
use
natur
compound
singl
combin
use
clinic
set
comparison
screen
therefor
valuabl
start
titrat
assay
use
proven
use
assay
measur
inhibitori
abil
plant
extract
rotavir
infect
contrast
assess
ter
reveal
inhibitori
compound
studi
rotaviru
strain
rrv
show
decreas
ter
even
though
previou
publish
data
shown
effect
rrv
ter
cho
et
show
absorpt
enhanc
like
acid
taurin
decreas
ter
cell
increas
permeabl
dosedepend
timedepend
manner
result
indic
absorpt
enhanc
widen
tight
junction
even
without
rotaviru
infect
futur
experi
use
ter
extract
increas
permeabl
without
rotaviru
infect
exclud
extract
data
demonstr
first
time
gener
use
nutrit
extract
nelumbo
nucifera
gaertn
aspalathu
lineari
burmf
rdahlgren
urtica
dioica
l
glycyrrhiza
glabra
l
olea
europaea
l
vitro
antivir
activ
rotaviru
none
plant
report
antivir
action
rotavirus
antivir
action
even
enhanc
combin
glycyrrhiza
glabra
l
nelumbo
nucifera
gaertn
andor
urtica
dioica
l
extract
indic
differ
mechan
action
therefor
combin
plant
potenti
use
treatment
diarrhea
caus
rotaviru
addit
file
appendix
list
test
herbal
extract
addit
file
appendix
list
test
pure
compon
abbrevi
simian
rotaviru
rrv
rhesu
rotaviru
inhibitori
concentr
cell
cultur
infect
dose
